Prenatal and postnatal ritodrine pharmacokinetics of women and twin neonates

• In: Posters: Pharmacokinetics/Pharmacodynamics & Systems Pharmacology
• At: Bangkok (Thailand) (2014)
• Type: Poster
• Poster code: POS-PAA003
• By: INOTSUME, Nobuo (Hokkaido Pharmaceutical University, Clinical Pharmacology, Otaru, Japan)
• Co-author(s): Soma, Mayuko (Tenshi Hospital, Otaru, Japan)
  Konda, Ainari (Hokkaido Pharmaceutical University, Otaru, Japan)
  Toda, Takaki (Hokkaido Pharmaceutical University, Otaru, Japan)
  Mukai, Yuji (Hokkaido Pharmaceutical University, Otaru, Japan)
  Kishimoto, Shuichi (Kobegakuin University, Kobe, Japan)
  Fukushima, Shoji (Kobegakuin University, Kobe, Japan)
  Fujieda, Satoko (Tenshi Hospital, Otaru, Japan)
  Yoshida, Hiroshi (Tenshi Hospital, Otaru, Japan)
  
• Abstract:

  Background
  Pregnant women in Japan requiring hospitalization for threatened labor often receive continuous infusions of ritodrine, a β2-selective agonist. Ritodrine can cross the placenta and its pharmacological effects in neonates can include tachycardia, hypoglycemia, and intestinal paralysis, which are matters of major concern.
  Aims
  To..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login